Annual Cash & Cash Equivalents
$69.23 M
+$10.37 M+17.61%
December 31, 2024
Summary
- As of March 13, 2025, TNDM annual cash & cash equivalents is $69.23 million, with the most recent change of +$10.37 million (+17.61%) on December 31, 2024.
- During the last 3 years, TNDM annual cash & cash equivalents has fallen by -$1.95 million (-2.74%).
- TNDM annual cash & cash equivalents is now -59.87% below its all-time high of $172.52 million, reached on December 31, 2022.
Performance
TNDM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$69.23 M
+$20.20 M+41.18%
December 31, 2024
Summary
- As of March 13, 2025, TNDM quarterly cash and cash equivalents is $69.23 million, with the most recent change of +$20.20 million (+41.18%) on December 31, 2024.
- Over the past year, TNDM quarterly cash and cash equivalents has increased by +$10.37 million (+17.61%).
- TNDM quarterly cash and cash equivalents is now -68.88% below its all-time high of $222.48 million, reached on June 30, 2020.
Performance
TNDM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TNDM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.6% | +17.6% |
| 3 y3 years | -2.7% | -59.9% |
| 5 y5 years | +35.3% | -59.9% |
TNDM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.9% | +17.6% | -59.9% | +45.1% |
| 5 y | 5-year | -59.9% | +35.3% | -68.9% | +45.1% |
| alltime | all time | -59.9% | +699.8% | -68.9% | +473.2% |
Tandem Diabetes Care Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $69.23 M(+17.6%) | $69.23 M(+41.2%) |
| Sep 2024 | - | $49.04 M(+2.8%) |
| Jun 2024 | - | $47.70 M(-19.1%) |
| Mar 2024 | - | $58.98 M(+0.2%) |
| Dec 2023 | $58.87 M(-65.9%) | $58.87 M(-26.1%) |
| Sep 2023 | - | $79.61 M(-39.1%) |
| Jun 2023 | - | $130.75 M(+2.3%) |
| Mar 2023 | - | $127.76 M(-25.9%) |
| Dec 2022 | $172.52 M(+142.4%) | $172.52 M(+39.4%) |
| Sep 2022 | - | $123.79 M(+7.7%) |
| Jun 2022 | - | $114.97 M(+22.7%) |
| Mar 2022 | - | $93.68 M(+31.6%) |
| Dec 2021 | $71.18 M(-24.8%) | $71.18 M(-36.7%) |
| Sep 2021 | - | $112.38 M(+14.0%) |
| Jun 2021 | - | $98.58 M(-18.4%) |
| Mar 2021 | - | $120.79 M(+27.7%) |
| Dec 2020 | $94.61 M(+84.9%) | $94.61 M(-26.9%) |
| Sep 2020 | - | $129.48 M(-41.8%) |
| Jun 2020 | - | $222.48 M(+198.7%) |
| Mar 2020 | - | $74.48 M(+45.5%) |
| Dec 2019 | $51.17 M(+22.4%) | $51.17 M(+11.1%) |
| Sep 2019 | - | $46.06 M(+20.7%) |
| Jun 2019 | - | $38.16 M(-5.7%) |
| Mar 2019 | - | $40.45 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $41.83 M(+205.3%) | $41.83 M(+29.4%) |
| Sep 2018 | - | $32.33 M(-36.0%) |
| Jun 2018 | - | $50.55 M(-19.2%) |
| Mar 2018 | - | $62.58 M(+356.8%) |
| Dec 2017 | $13.70 M(-69.3%) | $13.70 M(+13.4%) |
| Sep 2017 | - | $12.08 M(-55.8%) |
| Jun 2017 | - | $27.35 M(-32.2%) |
| Mar 2017 | - | $40.33 M(-9.7%) |
| Dec 2016 | $44.68 M(+3.7%) | $44.68 M(+148.8%) |
| Sep 2016 | - | $17.96 M(-40.6%) |
| Jun 2016 | - | $30.25 M(-25.5%) |
| Mar 2016 | - | $40.61 M(-5.8%) |
| Dec 2015 | $43.09 M(+38.2%) | $43.09 M(-0.3%) |
| Sep 2015 | - | $43.20 M(-5.9%) |
| Jun 2015 | - | $45.92 M(-26.6%) |
| Mar 2015 | - | $62.55 M(+100.6%) |
| Dec 2014 | $31.18 M(-74.9%) | $31.18 M(-12.3%) |
| Sep 2014 | - | $35.56 M(-44.6%) |
| Jun 2014 | - | $64.21 M(-16.4%) |
| Mar 2014 | - | $76.83 M(-38.2%) |
| Dec 2013 | $124.39 M(+624.7%) | $124.39 M(+699.9%) |
| Sep 2013 | - | $15.55 M(-48.4%) |
| Jun 2013 | - | $30.13 M(+75.6%) |
| Dec 2012 | $17.16 M(+98.3%) | $17.16 M |
| Dec 2011 | $8.66 M | - |
FAQ
- What is Tandem Diabetes Care annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tandem Diabetes Care?
- What is Tandem Diabetes Care annual cash & cash equivalents year-on-year change?
- What is Tandem Diabetes Care quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly cash and cash equivalents year-on-year change?
What is Tandem Diabetes Care annual cash & cash equivalents?
The current annual cash & cash equivalents of TNDM is $69.23 M
What is the all time high annual cash & cash equivalents for Tandem Diabetes Care?
Tandem Diabetes Care all-time high annual cash & cash equivalents is $172.52 M
What is Tandem Diabetes Care annual cash & cash equivalents year-on-year change?
Over the past year, TNDM annual cash & cash equivalents has changed by +$10.37 M (+17.61%)
What is Tandem Diabetes Care quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TNDM is $69.23 M
What is the all time high quarterly cash and cash equivalents for Tandem Diabetes Care?
Tandem Diabetes Care all-time high quarterly cash and cash equivalents is $222.48 M
What is Tandem Diabetes Care quarterly cash and cash equivalents year-on-year change?
Over the past year, TNDM quarterly cash and cash equivalents has changed by +$10.37 M (+17.61%)